Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: EASTON BIOPHARMACEUTICALS(688513) the Revenue is 332.64 M (-4.64%);the EBIT is 53.71 M (-31.51%);the EPS is 0.45 (+4.53%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.33B4.64%
----
----
EBIT
0.05B31.51%
----
----
EPS
0.44994.53%
----
----
Upcoming earnings report - Q3 FY2026
Available dateOct 28, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf